The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection
- PMID: 33005387
- PMCID: PMC7508780
- DOI: 10.1002/cld.911
The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection
Abstract
Watch a video presentation of this article.
© 2020 by the American Association for the Study of Liver Diseases.
Figures

Similar articles
-
Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management.Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):115-119. doi: 10.1002/cld.895. eCollection 2020 Mar. Clin Liver Dis (Hoboken). 2020. PMID: 32685137 Free PMC article. Review.
-
Consequences of not "knowing the patient".Clin Nurse Spec. 2000 Mar;14(2):75-81. doi: 10.1097/00002800-200003000-00010. Clin Nurse Spec. 2000. PMID: 11188452 Review.
-
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13. Gastroenterology. 2019. PMID: 30552895
-
Epidemiology of bacterial infections in patients with liver cirrhosis. Experience in a Spanish tertiary health center.Biomedica. 2016 Mar 3;36(1):121-32. doi: 10.7705/biomedica.v36i1.2600. Biomedica. 2016. PMID: 27622445
-
Deal watch: Novartis acquires marketing rights for novel broad-spectrum antibiotic.Nat Rev Drug Discov. 2009 Dec;8(12):922. doi: 10.1038/nrd3064. Nat Rev Drug Discov. 2009. PMID: 19949393 No abstract available.
Cited by
-
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.Future Sci OA. 2024 May 14;10(1):FSO945. doi: 10.2144/fsoa-2023-0160. eCollection 2024. Future Sci OA. 2024. PMID: 38813115 Free PMC article.
-
Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians.Antibiotics (Basel). 2023 Aug 15;12(8):1316. doi: 10.3390/antibiotics12081316. Antibiotics (Basel). 2023. PMID: 37627736 Free PMC article. Review.
-
Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis.World J Hepatol. 2023 Mar 27;15(3):377-385. doi: 10.4254/wjh.v15.i3.377. World J Hepatol. 2023. PMID: 37034233 Free PMC article. Review.
References
-
- Moreau R, Jalan R, Gines P, et al. Acute‐on‐chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426‐1437. - PubMed
-
- Piano S, Singh V, Caraceni P, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 2019;156:1368‐1380. - PubMed
-
- Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013;57:1651‐1653. - PubMed
-
- Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute‐on‐chronic liver failure: Prevalence, characteristics and impact on prognosis. Gut 2018;67:1870‐1880. - PubMed
-
- Medina E, Pieper DH. Tackling threats and future problems of multidrug‐resistant bacteria. Curr Top Microbiol Immunol 2016;398:3‐33. - PubMed
Publication types
LinkOut - more resources
Full Text Sources